Scientific highlights and perspectives from the International Inflammatory Breast Cancer Symposium 2025 - PubMed
3 days ago
- #Inflammatory Breast Cancer
- #Global Collaboration
- #Precision Medicine
- IBC is a rare but highly aggressive breast cancer subtype with poor patient outcomes despite research.
- Key themes include IBC biology, focusing on tumor emboli formation and tumor microenvironment interactions.
- Advances in molecular and immune profiling were highlighted for personalized therapy guidance.
- Trimodal therapy remains crucial for nonmetastatic IBC, with a need for novel agents and biologically informed strategies.
- Locoregional management optimization was discussed, including for selected metastatic patients.
- Emerging technologies like spatial transcriptomics, AI, and liquid biopsy show promise for better characterization, detection, and monitoring.
- Emphasis on expanding awareness, education, and global collaboration through the IBC International Consortium to standardize diagnosis and improve care access.